ArticleBiology2026
Identification and Characterization of
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Between 2022 and 2024, a severe branch dieback disease was observed affecting over 6% of sweet cherry trees of the 'Tieton' cultivar in commercial greenhouses in southern Liaoning Province, China. Symptoms primarily occurred at the top of young branches. At the early stage of disease onset, the lesions appeared as dark brown, irregularly shaped areas with a moist surface; as the disease progressed, these lesions turned dry and rotten, leading to tree decline symptoms in sweet cherry trees. Disease diagnosis was carried out in sweet cherry greenhouses across Liaoning Province, where 24 diseased samples were collected and 14 fungal isolates were obtained therefrom. Based on morphological traits, cultural characteristics, and multi-locus phylogenetic analyses of the internal transcribed spacer (ITS) region, beta-tubulin (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.